Company · CIK 0000891293
CTI BIOPHARMA CORP
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/ACTI BIOPHARMA CORP0000921895-23-001590 · 303.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-174551 · 248.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-156724 · 180.1 KBSEC(opens sec.gov)
- 10-QQuarterly update0000891293-23-000015 · 3.8 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-140076 · 1.1 MBSEC(opens sec.gov)
- SC 13GCTI BIOPHARMA CORP0000935836-23-000361 · 52.9 KBSEC(opens sec.gov)
- SC 13GCTI BIOPHARMA CORP0000935836-23-000345 · 31.6 KBSEC(opens sec.gov)
- 10-KAnnual report0000891293-23-000011 · 8.7 MBSEC(opens sec.gov)
- 8-KCurrent report0000891293-23-000009 · 312.3 KBSEC(opens sec.gov)
- SC 13G/ACTI BIOPHARMA CORP0000935836-23-000134 · 59.2 KBSEC(opens sec.gov)
Insiders
- ASELAGE STEVEEVP, Global Commercial Ops
- BAUER JOHN HDirector
- BAXTER INTERNATIONAL INC10% Owner
- BENNER STEVEN EEVP, Chief Medical Officer
- Bianco James A.Director
- BIANCO LOUIS AEVP, Finance & Administration
- BIOTECHNOLOGY VALUE FUND L PDirector, 10% Owner, See Explanation of Responses
- Biotechnology Value Trading Fund OS LPDirector, See Explanation of Responses
- BOWMAN JACK LDirector
- Brown JadeEVP, Chief Business Officer
Tickers
No tickers on record.
Addresses
business
3101 WESTERN AVENUE SUITE 800
SEATTLE, WA, 98121
mailing
3101 WESTERN AVENUE SUITE 800
SEATTLE, WA, 98121
Former names
- CELL THERAPEUTICS INC2014-05-29
Same industry